Erin Boykin Yates, PA

Erin Yates practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Erin Yates' NPI, 1306865100, was assigned on July 19, 2006. Erin Yates holds Texas license PA04639.

Erin Yates' primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Erin Yates' primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Erin Yates practices. Vendor and product names are available with a free account.

Physician assistant is Erin Yates' primary specialty in the NPI Registry, under taxonomy code 363A00000X. Erin Yates is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Erin Yates is licensed in Texas.

CMS data shows 145 Medicare services from Erin Yates across 3 procedure codes in 2024, all of them office visits, for 160 Medicare patients. Medicare paid $12,098 for them.

CMS counts 160 Medicare patients who saw Erin Yates in 2024. The largest group is 65 to 74, with 91 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Erin Yates' median patient age at 70, with 37% women.

In 2024, Erin Yates wrote 80 Medicare Part D claims for 40 patients. 76% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $15,515 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Erin Yates for performance year 2024, reported as part of a group. Erin Yates accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Erin Yates as offering telehealth.

CMS Open Payments shows 1 general payment to Erin Yates from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $18.